Quantum BioPharma Common Stock

The latest common stock for QNTM is $190M as of June 2026. That compares with $160M in the prior-year period — up 17.4% year over year. Investors often review this figure alongside Quantum BioPharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, QNTM's common stock moved from $160M to $190M — a 17.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Quantum BioPharma's operating scale or balance-sheet position.

A common stock figure of $190M for QNTM is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting QNTM's common stock ($190M), review year-over-year change from $160M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.